Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Julphar
Accenture
Mallinckrodt
Farmers Insurance
Federal Trade Commission
Chubb
McKinsey
Healthtrust
Cantor Fitzgerald

Generated: December 11, 2017

DrugPatentWatch Database Preview

Metaproterenol sulfate - Generic Drug Details

« Back to Dashboard

What are the generic sources for metaproterenol sulfate and what is the scope of metaproterenol sulfate patent protection?

Metaproterenol sulfate
is the generic ingredient in three branded drugs marketed by Boehringer Ingelheim, Apotex Inc, Astrazeneca, DEY, Mylan Speciality Lp, Nephron, Wockhardt, Muro, G And W Labs Inc, Morton Grove, Silarx, Am Therap, Par Pharm, Teva, Usl Pharma, and Watson Labs, and is included in thirty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for metaproterenol sulfate. Two suppliers are listed for this compound.

Pharmacology for metaproterenol sulfate

Medical Subject Heading (MeSH) Categories for metaproterenol sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Boehringer IngelheimALUPENTmetaproterenol sulfateSYRUP;ORAL017571-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaMETAPROTERENOL SULFATEmetaproterenol sulfateTABLET;ORAL072520-001Mar 30, 1990DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Am TherapMETAPROTERENOL SULFATEmetaproterenol sulfateTABLET;ORAL072054-001Jun 23, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
WockhardtMETAPROTERENOL SULFATEmetaproterenol sulfateSOLUTION;INHALATION075586-002May 30, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
WockhardtMETAPROTERENOL SULFATEmetaproterenol sulfateSYRUP;ORAL074702-001Mar 24, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Boehringer IngelheimALUPENTmetaproterenol sulfateAEROSOL, METERED;INHALATION016402-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Boehringer IngelheimALUPENTmetaproterenol sulfateTABLET;ORAL015874-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
DeyMETAPROTERENOL SULFATEmetaproterenol sulfateSOLUTION;INHALATION071805-001Aug 5, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SilarxMETAPROTERENOL SULFATEmetaproterenol sulfateSYRUP;ORAL073632-001Jul 22, 1992RXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
Am TherapMETAPROTERENOL SULFATEmetaproterenol sulfateTABLET;ORAL072055-001Jun 23, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: metaproterenol sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer IngelheimALUPENTmetaproterenol sulfateAEROSOL, METERED;INHALATION016402-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Boehringer IngelheimALUPENTmetaproterenol sulfateTABLET;ORAL015874-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Boehringer IngelheimALUPENTmetaproterenol sulfateSYRUP;ORAL017571-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Boehringer IngelheimALUPENTmetaproterenol sulfateTABLET;ORAL015874-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Boehringer IngelheimALUPENTmetaproterenol sulfateSOLUTION;INHALATION017659-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Boehringer IngelheimALUPENTmetaproterenol sulfateSOLUTION;INHALATION018761-001Jun 30, 1983► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Teva
Farmers Insurance
US Army
Harvard Business School
McKesson
AstraZeneca
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot